Patent · US Active

Sp1 polypeptides, modified Sp1 polypeptides and uses thereof

US9051379B2 · kind B2 · utility

6Cited by

4References

24Claims

0Family size

Assignees

Fulcrum SP Ltd. · IL
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. · IL

Inventors

Amnon Wolf · Herzliya, IL
Yehonathan Pouny · Givat Shmuel, IL
Ira Marton · Rehovot, IL
Or Dgany · Ashdod, IL
Arie Altman · Rehovot, IL
Oded Shoseyov · Karmei Yosef, IL

Key dates

Filing date	Jul 9, 2006
Grant date	Jun 9, 2015
Priority date	—
Expiry date	Oct 17, 2026

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

SP1 and modified SP1 variant polypeptides capable of forming reversible molecular associations with substances, compositions-of-matter comprising same, and uses thereof are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.